Immunotherapy has demonstrated significant benefits in recent large trials, reaching new survival benchmarks for upper gastrointestinal cancers across various settings of disease, according to Jaffer A. Ajani, MD.
https://www.targetedonc.com/view/immunotherapy-reaches-new-heights-in-upper-gi-cancer-trials